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Abstract
Fasciola hepatica (liver fluke), a significant threat to food security, causes global economic loss for the livestock industry and is
re-emerging as a foodborne disease of humans. In the absence of vaccines, treatment control is by anthelmintics; with only
triclabendazole (TCBZ) currently effective against all stages of F. hepatica in livestock and humans. There is widespread
resistance to TCBZ and its detoxification by flukes might contribute to the mechanism. However, there is limited phase I capacity
in adult parasitic helminths with the phase II detoxification system dominated by the soluble glutathione transferase (GST)
superfamily. Previous proteomic studies have demonstrated that the levels of Mu class GST from pooled F. hepatica parasites
respond under TCBZ-sulphoxide (TCBZ-SO) challenge during in vitro culture ex-host. We have extended this finding by
exploiting a sub-proteomic lead strategy to measure the change in the total soluble GST profile (GST-ome) of individual
TCBZ-susceptible F. hepatica on TCBZ-SO-exposure in vitro culture. TCBZ-SO exposure demonstrated differential abundance
of FhGST-Mu29 and FhGST-Mu26 following affinity purification using both GSH and S-hexyl GSH affinity. Furthermore, a
low or weak affinity matrix interacting Mu class GST (FhGST-Mu5) has been identified and recombinantly expressed and
represents a new low-affinity Mu class GST. Low-affinity GST isoforms within the GST-ome was not restricted to FhGST-Mu5
with a second likely low-affinity sigma class GST (FhGST-S2) uncovered. This study represents the most complete Fasciola
GST-ome generated to date and has supported the potential of subproteomic analyses on individual adult flukes.
Keywords Affinity chromatography . Anthelmintic . Glutathione transferases . Proteomics
Introduction
Fasciolosis, caused by the trematode liver flukes Fasciola
hepatica and F. gigantica, is a foodborne zoonotic affecting
grazing animals and humans worldwide (Andrews 1999).
Liver fluke causes economic losses of over US$3 billion
worldwide per annum to livestock via a decrease in produc-
tion of milk, meat and wool, susceptibility to other infections,
condemnation of livers and mortality (Boray 1997). There are
no commercial vaccines as yet available, with triclabendazole
(TCBZ) currently the most commonly used fasciolicide due to
its activity against both adults and juvenile stage fluke
(Brennan et al. 2007). TCBZ is absorbed in the rumen and
passes through the blood to the liver where it is rapidly
oxidised to the likely main active metabolites: triclabendazole
sulphoxide (TCBZ-SO) (Alvarez et al. 2005) and
triclabendazole sulphone (TCBZ-SO2) (Alvarez et al. 2009;
Alvarez et al. 2005). Unfortunately, TCBZ-resistant liver
flukes are wide spread, with resistance first encountered in
Australia; but it is now evident in Western Europe (Brennan
et al. 2007) including the UK (Thomas et al. 2000).
At present, our understanding of the mode of action and
detoxification of TCBZ is fragmented and mechanisms under-
pinning resistance may need to be resolved in order to measure
early TCBZ resistance in populations and thus preserve effica-
cy (Brennan et al. 2007). To this end, the glutathione transfer-
ase (GST) superfamily have been identified as the major phase
II detoxification system present in all parasitic helminths. GSTs
have been implicated in both drugmetabolism and resistance in
other groups of organisms, e.g. insects and human tumours
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(Hayes and Pulford 1995). Eight cytosolic GST classes have
been identified and are often species-independent, including
Alpha, Mu, Pi, Omega, Sigma, Theta, Phi and Zeta
(Mannervik et al. 2005). In F. hepatica, GSTs belonging to
four classes have been revealed by biochemistry and bioinfor-
matics: Omega (ω), Mu (μ), Sigma (σ) and Zeta (ζ) (Chemale
et al. 2006;Morphew et al. 2012). Chemale et al. (2010) further
reported that Mu class GST levels vary, with Mu class GST-1
reduced in abundance while Mu class GST-26 increased in
TCBZ-resistant and susceptible F. hepatica under TCBZ
sulphoxide (TCBZ-SO) exposure. In addition, Scarcella et al.
(2012) identified that fluke resistant to TCBZ expressed signif-
icantly higher levels of GST activity compared to susceptible
flukes. Furthermore, an amino acid mutation in Mu class GST-
26 has been linked to a TCBZ-resistant liver fluke strain
(Fernandez et al. 2015). However, to date, there has not been
a robust sub-proteomic study that compared the expression of
GST isotypes in individual liver fluke under TCBZ-SO stress.
Thus, we purified GSTs from the cytosol of single adult flukes
using a combination of glutathione (GSH) and S-hexyl-GSH
agarose, resolved GST isotypes by 2-DE and identified indi-
vidual GSTs by MS/MS with the support of genomic and
transcriptomic databases. As a consequence, we have identified
a novel Mu, Sigma and Omega class GST-designated FhGST-
Mu5, FhGST-S2 and FhGST-O2 respectively. FhGST-Mu5
has been cloned and expressed in a recombinant and active
form and characterised.
Materials and methods
In vitro TCBZ culture
Individual liver flukes from natural infections were collected
and exposed to TCBZ-SO as described previously (Morphew
et al. 2014). In brief, live adult F. hepaticawere collected from
a local abattoir (Randall Parker Foods, Llanidloes, Wales,
UK) and washed in PBS at 37 °C. Flukes were washed for
1 h with PBS replacement every 15 min. Post-washes, repli-
cates of 10 adult, sizedmatched, wormswere placed into fluke
Dulbecco’s Modified Eagle Medium (DMEM) culture media
containing 15 mM HEPES, 61 mM glucose, 2.2 mM calcium
acetate, 2.7 mM magnesium sulphate, 1 μM serotonin and
gentamycin (5 μg/ml) as previously described (Morphew
et al. 2011). Flukes were maintained in culture at 37°C for
2 h (including transport to the laboratory) to establish a base-
line protein expression profile. Upon completion of the initial
2-h incubation, culture media was replaced and supplemented
with TCBZ-SO (LGC Standards, UK) at 50 μg/ml (lethal
dose) or 15 μg/ml (sub-lethal dose) in DMSO (final conc.
0.1% v/v). For control samples, only DMSO was added to a
final volume of 0.1% v/v. Fluke cultures were then allowed to
incubate at 37°C for a 6-h time period after which the media
was refreshed, with DMSO and TCBZ-SO as required. Fluke
cultures were incubated at 37°C for a further 6 h. A final
refreshment of culture media was conducted and fluke cul-
tures incubated for an additional 12 h at 37 °C. Upon comple-
tion of the culture, flukes were removed from the media and
snap frozen individually in liquid N2. All samples were stored
at − 80°C until required.
GST assay and purification
Individual adult F. hepaticawere homogenised in an all-glass
homogeniser on ice using 2 ml of lysis buffer containing
20 mM potassium phosphate pH 7.4, 0.1% v/v Triton-X 100
and EDTA-free protease inhibitors (Roche, Complete-Mini,
EDTA-free). Samples were centrifuged at 100,000×g for
45min at 4 °C to obtain the supernatant, the cytosolic fraction.
Protein levels were quantified by the method of Bradford
(1976). GST enzymatic specific activity was determined ac-
cording to the conditions outlined by Habig et al. (1974) de-
scribed previously (LaCourse et al. 2012) and stored at − 80
°C until needed. Briefly, GST activity was measured using
1 mM of the model substrate 1-chloro-2,4-dinitrobenzene
(CDNB) and 1 mM reduced GSH in 20 mM potassium phos-
phate pH 6.5 and 25 °C. Activity was monitored at 340 nm
over a period of 3 min. Specific activity data was log10 trans-
formed prior to statistical comparison carried out by a two-
way ANOVA.
Cytosolic proteins were applied to a GSH-agarose (Sigma-
Aldrich) or an S-hexyl-GSH-agarose (Sigma-Aldrich) affinity
matrix and purified at 4°C according to the manufacturer’s
instructions and as described previously (Morphew et al.
2012). Eluted proteins were concentrated using 10-kDa mo-
lecular weight cutoff filters (Amicon Ultra, Millipore) and
washed with ddH2O. All samples were quantified again by
the method of Bradford (Sigma-Aldrich).
Protein preparation and 2-DE
IPG strips (7 cm, linear pH 3–10) were rehydrated with 100 μl
of buffer (containing 8 M Urea, 2% w/v CHAPS, 33 mM
DTT, 0.5% ampholytes pH range 3–10) plus 25 μl of sample
protein and ddH2O to load 20 μg of GSH or Hexyl-GSH
affinity bound proteins. Samples were in-gel rehydrated for
16 h and isoelectrically focused on 7 cm pH 3–10 IPG strips to
10,000 Vh on a Protean® IEF Cell (BioRad). After focusing,
strips were then equilibrated for 15 min in reducing equilibra-
tion buffer (30% v/v glycerol, 6 M urea, 1% DTT) followed
by 15min in alkylating equilibration buffer (30% v/v glycerol,
6 M urea, 4% iodoacetamide). IPG strips were run upon SDS
PAGE (12.5% acrylamide) using the Protean® II 2-D Cell
(BioRad). Gels were then Coomassie blue stained (Phastgel
Blue R, Amersham, Biosciences), and imaged on a GS 800
calibrated densitometer (BioRad). Quantitative differences
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between 2-DE protein spots were analysed using Progenesis
PG220, software version 200 (Nonlinear Dynamics Ltd.),
using 5 biological replicates. Spots were automatically detect-
ed on gels and manually edited. Normalisation of spots was
calculated using total spot volume multiplied by the total vol-
ume (Moxon et al. 2010). All gel images were warped using
manual matching before average gels (5 gels were used to
make the average gels) for each treatment group were pro-
duced. Unmatched protein spots were also detected on appro-
priate gel comparisons. Two-fold differences between protein
spots with a p < 0.05 were considered significant when aver-
age gels were compared.
Western blotting
Following 2-DE, resolved proteins were transferred to nitrocel-
lulose membranes. The nitrocellulose membrane was soaked in
ddH2O for 1 min. The gel, membrane, filter paper and porous
pads were equilibrated in 1× Western Blot Transfer Buffer
(NuPAGE Transfer Buffer, Life Technologies) for 20 min.
Proteins were transferred at 40 V for 2 h in 1×Western blot
transfer buffer (50 ml NuPage transfer Buffer, 850 ml ddH2O,
100 ml methanol). To ensure proteins were transferred, the
membrane was removed and stained with Amido black stain-
ing solution (0.1% w/v Amido black, 10% v/v Acetic Acid,
25% v/v isopropanol) for 1 min to detect the success of the
transfer. The membrane was then washed with ddH2O. The
membrane was then placed in Amido black de-stain (25% v/v
isopropanol and 10% v/v acetic acid) for 30 min. The mem-
brane was imaged using the GS-800 calibrated densitometer
(BioRad). Amido black stain was removed with several
washes of Tris-buffered saline, 1% v/v Tween 20 (TTBS).
The nitrocellulose membrane was blocked in blocking
buffer (TTBS + 5% milk powder) overnight. The membrane
was then washed with TTBS and then incubated with the
primary antibody for 1–2 h. A 1:5,000 dilution and a
1:30,000 antibody dilution in blocking buffer was used for
anti-Mu and anti-Sigma GST respectively. After incubation
with the primary antibody, the membrane was washed in
TBS for 10 min. The membrane was washed twice more be-
fore incubating with the secondary antibody (anti-goat IgG
raised in rabbits for the Mu and anti-rabbit IgG raised in goats
for the Sigma) for 1–2 h at a 1:30000 dilution in blocking
buffer. The membrane was then washed 3 times in Tris-
buffered saline (TBS). Interacting spots or bands were detect-
ed using the 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in
conjugation with nitro blue tetrazolium (NBT), according to
manufacturer’s instructions. To develop, a 1:2 solution of
BCIP:NBT in substrate buffer consisting of 0.1 M tris,
100 mM NaCl and 5 mM magnesium chloride, adjusted to
pH 9.5. To cease the over development, membranes were
rinsed in ddH2O. Blots were then scanned with a GS-800
calibrated densitometer (BioRad) and were imaged using
Quantity One Version 4.6 software (BioRad, UK).
Protein identification
Protein spots were manually excised from the gels and in-gel
digested with trypsin according to the method of Chemale
et al. (2006). Tandem mass spectrometry (MSMS) was per-
formed according to the method described by Moxon et al.
(2010) Briefly, selected peptides from peptide digests were
loaded onto a gold coated nanovial (Waters, UK), and sprayed
at 800–900 V at atmospheric pressure and fragmented by
collision-induced dissociation using argon as the collision
gas. Mass Lynx v 3.5 (Waters, UK) ProteinLynx was used
to process the fragmentation spectra. Each fragmented spec-
trum was individually processed as follows: each spectrum
was combined and smoothed twice using the SavitzkyGolay
method ± 3 channels, background subtraction (polynominal
order 15 and 10% below the curve). Each spectrum was
exported and spectra common to each 2-DE spot were merged
into a single MASCOT generic format (.mgf) file using the
online peak list conversion utility available at www.
proteomecommons.org (Falkner et al. 2007).
Mass spectrometry database analysis
Merged files were submitted to MASCOT MSMS ion search
set to search the published F. hepatica genomes (Cwiklinski
et al. 2015; McNulty et al. 2017). The following parameters
were selected for each peptide search: enzyme set at trypsin
with one missed cleavage allowed, fixed modifications set for
carbamidomethylation with variable modifications considered
for oxidation of methionine, monoisotopic masses with unre-
stricted protein masses were considered, peptide and fragment
mass tolerance were set at ± 1.2 Da and 0.6 Da respectively for
an ESI QUAD-TDF instrument (Moxon et al. 2010).
In silico investigation of Fasciola transcripts and
F. hepatica genome
Sequences representing known GST classes were obtained
from NCBI (http://www.ncbi.nlm.nih.gov/). A mammalian
and a helminth GST sequence were selected for each GST
class where available. GST sequences were used to
tBLASTn the F. hepatica transcriptome (Young et al. 2010)
and the F. gigantica transcriptome (Young et al. 2011) both
available to search at http://bioinfosecond.vet.unimelb.edu.au/
wblast2.html. A second F. hepatica transcriptome database
(EBI-ENA archive ERP000012: an initial characterisation of
the F. hepatica transcriptome using 454-FLX sequencing)
was also used to search against. In silico investigation of the
known GST sequences and positive transcript hit were blasted
against genome sequencing project of F. hepatica (Cwiklinski
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et al. 2015) and F. gigantica (Choi et al. 2020). The genome of
Choi et al. (2020) was chosen over that of Pandey et al. (2020)
as the data is freely accessible through NCBI GenBank and
Wormbase Parasite. Transcript expression levels for
individual F. hepatica GST isoforms were analysed from
Cwiklinski et al. (2018) Each specific GST isoform was used
to BLASTp the transcriptome to identify the respective ex-
pression level.
Cloning of newly identified genes
PCR amplification was carried out on an Applied Biosystems
96Well Thermal Cycler. PCR of cDNA was performed using
MyFi Taq (Bioline) following the manufacturer’s instructions.
Standard thermocycler conditions involved an initial denatur-
ation at 95 °C for 2 min, followed by 25–35 cycles of dena-
turation (95 °C, 30 s), annealing (gradient temperature specific
for each gene of interest, 30 s) and extension (72 °C, 30–90 s),
before a final extension at 72 °C for 5 min and holding period
at 4 °C until products removed. Primers were based on the
scaffolds from the F. hepatica genome (FhGST-S2 For:
GGGCGATACTATCTATCAACGT Rev: GTGCGACT
GACTTTGAATC; FhGST-O2 For: CACACAGCTGGAAT
TGA TTA Rev: TAATATTGACGGATCCAAACA). PCR
products were ligated into pGEM-T-Easy, according to the
manufacturer’s protocol and sequenced in house. Sequences
were translated using Expasy Translate (https://web.expasy.
org/translate/) and molecular weight and pI calculated using
Expasy Compute pI/Mw (https://web.expasy.org/compute_
pi/). GST domains were predicted using PFam (El-Gebali
et al. 2019).
Protein sequence alignment and phylogenetic tree
construction
All sequences were aligned using ClustalW through BioEdit
Version 7.0.5.3 (10/28/05) (Hall 1999). To construct a phylo-
genetic tree, an alignment of all GST sequences was exported
into Molecular Evolutionary Genetics Analysis (MEGA) soft-
ware version X (Tamura et al. 2007). Analysis was performed
using a neighbour-joining method, 1000-replicate,
bootstrapped tree. The amino acid data were corrected for a
gamma distribution (level set at 1.0) and with a Poisson
correction.
Recombinant Fasciola hepatica glutathione
transferase Mu class (rFhGST-Mu5) production
FhGST-Mu5 was amplified via PCR using the following
primer pair: rFhGST-Mu5 forward primer, 5′ CATA
TGGCTCCAGTCTTA 3′; rFhGSTMu5 reverse primer, 5′
GCGGCCGCTTAACTGGGTGGTGCA 3′; and a second
reverse primer containing the stop codon 5′ GCGGCCGC
ACTTTAACTGGGTGGTGCA 3′. Restriction enzyme sites
(in bold type and underlined) for NdeI (forward primer) and
NotI (reverse primer) were included so that the entire ORF
could be directly cloned into the pET23a (Novagen) vector.
Recombinant proteins were produced in Escherichia coli
BL21 (DE3) cells (Bioline) as described previously
(LaCourse et al. 2012; Morphew et al. 2012).
E.coli preparations containing rFhGST-Mu5 were
suspended in lysis buffer (containing 5 mM MgCl, 400 mM
NaCl and 20 mM sodium phosphate pH 7.4) and were lysed
through a freeze/thaw method, freezing in liquid nitrogen
followed by thawing at 42 °C three times. This was followed
by 3 cycles of ultrasonication; the samples were sonicated for
30 s with 30-s intervals in ice. The samples were centrifuged at
13,200×g for 20 min at 4°C, and purified by GSH affinity
chromatography as described previously.
Results
Limited induction of soluble F. hepatica GST by TCBZ-
SO
Prior to affinity chromatography, GST enzymatic specific ac-
tivity was assessed to examine if overall cytosolic GST activ-
ity was induced by TCBZ-SO exposure (Table 1). In general,
there was a trend to increased GST-specific activity following
exposure to TCBZ-SO for treatment groups compared to con-
trols (Online Resource 1). However, following ANOVA, no
significant difference was noted between any of the treatment
groups or the controls (2df, F = 1.25, P = 0.320).
GST proteomic profiling of individual fluke
Two affinity matrices were used to isolate GST isoforms
from individual adult F. hepatica. Eighteen individuals
were homogenised independently and all 18 independently
processed through GSH or S-Hexyl GSH agarose columns
to separate F. hepatica GST proteins from other soluble
proteins. Following purification, it was possible to compare
the GST-ome from each individual F. hepatica exposed to
TCBZ-SO, either a sub-lethal concentration (15 μg/ml) or a
lethal concentration (50 μg/ml), versus those not exposed
using 2-DE proteomics.
Proteomic arrays of the GSTs purified from S-hexyl
GSH-agarose consistently yielded 13 protein spots (Fig.
1a), whereas those purified from GSH-agarose column
yielded 11 prominent protein spots (Fig. 1b). All protein
spots from both purification systems were confirmed as
containing FasciolaGSTs using tandem mass spectrometry
(Table 2; full proteomic analysis Online Resource 2).
Comparison of 2-DE protein arrays was then performed to
establish if there was a change in abundance of the
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identified GSTs relating to the different treatment of TCBZ-
SO (Fig. 1c–f).
When comparing the S-Hexyl GSH control array with both
the S-Hexyl GSH TCBZ-SO exposed arrays (Fig. 1a, c and e),
it was noted that spot 14 was present on all control arrays, thus
present on the average control array. However, the presence of
this protein spot varied on the TCBZ-SO treatment arrays
(sub-lethal and lethal). This particular protein spot was only
present on 2 sub-lethal arrays (numbered in Fig. 1c) and 1
lethal array (not visible on the representative array shown in
Fig. 1e). MSMS analysis identified this spot as Mu class
GST29 (THD21358).
The comparison of the arrays produced via GSH agarose
affinity columns identified two protein spots of interest when
the average control and average sub-lethal arrays were exam-
ined with both spots increased in abundance in sub-lethal
samples: spot 5, Mu class GST 26 (1df, F = 3.89, P = 0.089)
and spot 7, Mu class GST 29 (1df, F = 4.83, P = 0.064) both
approaching statistical significance (Fig. 1b and d; Online
Resource 3). No additional changes in protein abundance
were observed for GSH purifications.
GST expression in the cytosol of individual fluke and
affinity binding
Given the recorded potential of Mu class GSTs
responding to TCBZ-SO exposure, Western blotting was
used to estimate the number of Mu class GSTs present in
liver fluke cytosol prior to affinity chromatography, given
previous indications that some GST isoforms may fail to
bind to affinity matrices (Brophy et al. 1990). Assays
were undertaken on five individual adult flukes using an-
ti-S. mansoni Mu class polyclonal antibodies, previously
shown to recognise F. hepatica Mu class GSTs (Chemale
et al. 2006). The anti-flatworm GST Mu class antibody
recognised 8 GST subunits within the cytosolic profile
(Fig. 2a). Post purification, the blot patterns display the
same distinctive GST protein profiles following both GSH
and S-Hexyl GSH affinity 2-DE gels (Fig. 2b, c). A dis-
tinctive and reproducible 2-DE GST profile provides evi-
dence that 8 GST subunits are recognised by the Mu an-
tibody post purification.
Bioinformatic characterisation of GSTs identified in
F. hepatica
Following analysis of available transcript and genome se-
quences, the known 4 Mu class GSTs were identified along-
side a fifth Mu class GST designated FhGST-Mu5. Following
cloning and sequencing of FhGST-Mu5, multiple alignment
of all Mu class GSTs of F. hepatica revealed the extent of
identity and similarity across this class of GSTs (Fig. 3a).
Amino acid sequence similarity when comparing the newly
identified FhGST-Mu5 (GenbankMT613329) with the previ-
ously known F. hepaticaMu class GSTs identified the closest
sequence similarity was with FhGST-7 at approximately 54%.
It is also worth noting that GenBank entry THD26413
matches to FhGST-Mu5 with 91.9% sequence identity but is
an incomplete sequence lacking the N-terminus. When tran-
script expression was analysed for FhGST-Mu5 based on
Cwiklinski et al. (2018), the levels of transcript within the
adult are significantly lower than those in alternative life cycle
stages such as metacercariae and newly excysted juveniles
from 1 to 24 h (Fig. 3b). Of note was the identification of a
homologue of FhGST-Mu5 within F. gigantica. Two acces-
sion numbers (TPP60771 and TPP66459) were retrieved from
genome searches albeit both representing incomplete
sequences.
Further transcript and genome investigation allowed the ex-
amination of the complete GST-ome of F. hepatica and a more
complete understanding of F. gigantica. In addition to FhGST-
Mu5, in silico investigation revealed the identification of a
second Sigma class and a second Omega class GST within
F. hepatica. Bioinformatic characterisation of the new
FhGST-S2 and FhGST-O2 was undertaken to identify the
structural features and characteristics of these genes/proteins.
Only a single homologue for each was identified in the original
F . h e p a t i c a g e n om e . F o r F hG ST - S 2 , g e n e
BN1106_s1104B000225 (Scaffold 1104) was identified yet
this is now fragmented and incomplete in the most recent ver-
sion of the genome (PRJEB25283) despite transcript support
(Online Resource 4). In addition, a F. gigantica homologue of
FhGST-S2 was also identified in the recent genome
(TPP56382). However, unlike F. hepactica, the F. gigantica
genome revealed a third potential Sigma class GST (FgGST-
S3; TPP56383). For FhGST-O2, gene BN1106_s50B000678
Table 1 GST-Specific activity
assays of F. hepatica GST
samples exposed to TCBZ-SO
Treatment Total activity (nmol/min) Total protein (mg) Specific activity (nmol/min/mg)
Control 4463.44 8.55 522.04 ± 77.92
Sub-lethal 6002.92 10.52 570.62 ± 190.46
Lethal 6190.82 9.35 662.12 ± 134.63
TCBZ-SO at Control (0 μg/ml), sub-lethal (15 μg/ml) or lethal (50 μg/ml) dose. Total activity (nmol/min), total
protein (mg) and specific activity (nmol/min/mg) are included
983Parasitol Res (2021) 120:979–991

















1 243 490 0.8 GST 39 8 ADP09370 Mu 26/51 –
216 D915_15048 GST 31 5 THD18760 Mu 27/47
209 1184 0.31 GST 26 5 P31671 Mu 28/7
225 1043 0.18 GST 21 5 ABI79450 S1
62 D915_11958 GST 16 8 TPP64849 Mu 29/1
2 125 490 0.8 GST 26 6 ADP09370 Mu 26/51 –
105 D915_15048 GST 25 5 THD18760 Mu 27/47
100 1043 0.18 GST 21 5 ABI79450 S1
173 D915_11958 GST 10 5 TPP64849 Mu 29/1
92 D915_13000 GST 9 2 THD20590 Mu 28/7
49 61 0.52 TTL 3 2 – –
3 165 490 0.8 GST 48 9 ADP09370 Mu 26/51 –
154 490 0.5 GST 34 5 P31670 Mu 27/47
79 D915_13000 GST 11 2 THD20590 Mu 28/7
4 421 490 0.8 GST 84 11 ADP09370 Mu 26/51 –
346 1184 0.31 GST 55 7 P31671 Mu 28/7
345 490 0.5 GST 60 6 P31670 Mu 27/47
67 2285 0.12 GST 6 3 THD21358 Mu 29/1
5 1009 490 0.8 GST 165 15 ADP09370 Mu26/51 GSH SL ↑
769 1184 0.31 GST 114 12 P31671 Mu 28/7
859 490 0.5 GST 111 9 P31670 Mu 27/47
128 D915_11958 GST 48 12 TPP64849 Mu 29/1
162 D915_13524 HP 25 1 – –
52 1043 0.18 GST 5 3 ABI79450 S1
61 61 0.52 TTL 3 2 – –
6 645 1184 0.31 GST 113 12 P31671 Mu 28/7 –
597 490 0.8 GST 112 12 ADP09370 Mu 26/51
643 D915_15048 GST 90 9 THD18760 Mu 27/47
284 D915_11958 GST 55 12 TPP64849 Mu 29/1
54 1043 0.18 GST 13 6 ABI79450 S1
7 868 D915_11958 GST 177 19 TPP64849 Mu 29/1 GSH SL ↑
203 490 0.8 GST 64 11 ADP09370 Mu 26/51
210 1184 0.31 GST 59 10 P31671 Mu 28/7
192 490 0.5 GST 59 9 P31670 Mu 27/47
154 1043 0.18 GST 15 7 ABI79450 S1
8 No significant hits –
9 220 1184 0.31 GST 49 11 P31671 Mu 28/7 –
216 D915_15048 GST 43 8 THD18760 Mu 27/47
189 2285 0.13 GST 35 7 THD20842 Mu 26/51
171 D915_11958 GST 32 11 TPP64849 Mu 29/1
53 1043 0.18 GST 10 5 ABI79450 S1
10 115 D915_15048 GST 44 9 THD18760 Mu 27/47 –
106 1184 0.31 GST 36 6 P31671 Mu 28/7
66 D915_12658 GST 29 6 THD20842 Mu 26/51
11 217 1043 0.18 GST 28 7 ABI79450 S1 –
100 490 0.8 GST 19 7 ADP09370 Mu 26/51
87 D915_13000 GST 8 2 THD20590 Mu 28/7
12 302 1043 0.18 GST 34 9 ABI79450 S1 –
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(Scaffold 50) was revealed and is now designated as maker-
scaffold10x_938_pilon-snap-gene-0.52/D915_03058. This
was mirrored within F. gigantica (TPP65079). Each gene
encoded for a predicted single protein isoform.
Both the newly predicted FhGST-S2 and FhGST-O2
were cloned (Online Resource 5a) and sequenced.
Confirmation of the correct class assignment was per-


















68 2285 0.13 GST 8 2 THD20842 Mu 26/51
51 D915_13000 GST 4 1 THD20590 Mu 28/7
13 439 490 0.8 GST 86 14 ADP09370 Mu 26/51 –
401 1184 0.31 GST 63 13 P31671 Mu 28/7
419 490 0.5 GST 63 8 P31670 Mu 27/47
111 1043 0.18 GST 28 10 ABI79450 S1
130 D915_11958 GST 25 9 TPP64849 Mu 29/1
14 98 2285 0.12 GST 12 5 THD21358 Mu 29/1 HexGSH
SL↓ L↓↓
MASCOT ion scores of > 42 indicate identity or extensive homology (p < 0.05). An accession number fromGenBank relating to the top scoring BLAST
hit to determine GST isoform is also reported. Changes in abundance (↑ or ↓) are denoted for 2DE spots responding to sub-lethal or lethal (SL or L)
TCBZ-SO exposure for either purificationmethod (GSH or Hex-GSH). a For hits from the PRJEB25283 genome version only numbers are provided that
correspond to those numbers outlined in bold in the full name; maker-scaffold10x_000_pilon-snap-gene-0.0. b GST: glutathione transferase; TTL:
tubulin-tyrosine ligase family protein; HP: hypothetical protein
Fig. 1 Representative 2-DE arrays of GSTs purified from F. hepatica
using S-hexyl GSH and GSH agarose columns following TCBZ-SO ex-
posure. (a) S-hexyl GSH agarose-purified GSTs from control samples
(TCBZ-SO 0 μg/ml). (b) GSH agarose-purified GSTs from control sam-
ples (TCBZ-SO 0 μg/ml). (c) S-hexyl GSH agarose-purified GSTs from
sub-lethal samples (TCBZ-SO 15 μg/ml). (d) GSH agarose-purified
GSTs from sub-lethal samples (TCBZ-SO 15 μg/ml). (e) S-hexyl GSH
agarose-purified GSTs from lethal samples (TCBZ-SO 50 μg/ml). (f)
GSH agarose-purified GSTs from lethal samples (TCBZ-SO 50 μg/ml).
Spot numbers relate to GST putative identifications seen in Table 2. Spot
14 shown in (a) and (c) was only present on 1 replicate of the lethal arrays
and is therefore not shown in the representative array shown in (e)
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and 5c) and comparison of gene intron exon structure
(Online Resource 6). Of note was a significant N-
terminal extension of 20 amino acids in FhGST-S2 when
compared to FhGST-S1. FhGST-O2 in comparison to
FhGST-O1 revealed the addition of 1 amino acid to each
of exons 1 and 5. Further confirmation of class assign-
ment was supported with both FhGST-S2 and FhGST-O2
subjected to a PFam domain analysis revealing key-
predicted GST features: FhGST-S2 with a predicted C-
terminal domain (PFam GST_C_3) and FhGST-O2 with
a predicted N- and C-terminal domain (PFam GST_N_3
and GST_C_2).
Following a full phylogenetic analysis of the com-
pleted F. hepatica GST-ome, all of the newly identified
FhGST-Mu5, FhGST-S2 and FhGST-O2, in addition to
the F. gigantica homologues, were assigned to their
respective clades (Fig. 4). Of note is the close associa-
tion of FhGST-Mu5 to the Schistosome Mu class GSTs
rather than to the previously established four Fasciola
Mu class isoforms.
Expression, purification and characterisation of
rFhGST-Mu5
Full sequence length recombinant F. hepatica Mu class GST
(rFhGST-Mu5) was expressed and purified from transformed
E. coli cytosol following expression in BL21 (DE3) cells.
Purity was assessed on SDS-PAGE gels (Fig. 3c).
Interestingly, rFhGST-Mu5 was not able to be produced as a
pure protein with significant levels of contaminating E. coli
proteins remaining in the sample following GSH affinity pu-
rification. However, rFhGST-Mu5 was produced as an active
protein for further studies displaying enzymatic activity to-
wards the model GST substrate 1-chloro-2,4-dinitrobenzene
(CDNB). The specific activity for the rFhGST-Mu5 prepara-
tion was confirmed at 243.27 ± 92.45 nmol/min/mg.
Discussion
The 2-DE mapping of GSTs has been shown to be a useful
tool to delineate the function of individual members of this
soluble protein superfamily (Chemale et al. 2006; Morphew
et al. 2012), particularly as these proteins play a role in phase
II detoxification (Cvilink et al. 2009). To date, research has
only been completed on pooled cytosol samples from wild-
type fluke and defined isolates and there has not been a robust
sub-proteomic study that compared the expression of GST
isotypes in individual fluke populations under TCBZ-SO
challenge in culture. This study has adapted the pooled ap-
proach and, for the first time, performed analytical scale 2-
DE mapping of GSTs from individual F. hepatica adult
parasites. Thus, GSTs were purified from the cytosol of
single adult flukes using either S-Hexyl-GSH or GSH aga-
rose columns, resolved using analytical 2-DE and identified
individual GSTs by MSMS with the support of liver fluke
transcriptomic and genomic databases. In doing so, we can
identify individual fluke responses within the GST super-
family following exposure to chemotherapeutics.
Furthermore, this finding has major implications for future
population and resistance monitoring studies specifically
on, but not limited to, liver fluke GSTs.
In the current study, both S-Hexyl GSH agarose and GSH
agarose columns were used for GST purification at the indi-
vidual fluke level. Previous studies (Chemale et al. 2006;
Morphew et al. 2012) have demonstrated that S-Hexyl GSH
agarose columns have the ability to purify a greater range of
GSTs in both F. hepatica and F. gigantica population mixes
respectively, thus was a useful inclusion in the current work at
the individual fluke level. Using biochemical techniques and
analytical sub-proteomics identified both Sigma and Mu class
GSTs purified from individual adult F. hepatica. It was con-
firmed that both S-Hexyl GSH and GSH agarose columns
have the ability to purify both Mu and Sigma class GSTs,
Fig. 2 Assessment of Mu class GST binding affinity through Western
blotting with anti-S. mansoniMu of affinity-purified GSTs in comparison
to cytosolic fractions. (a) Visualisation of 100 μg TCA precipitated cyto-
solic proteins of F. hepatica adult worms using two-dimensional gel
electrophoresis (2-DE) and Western blot analysis probing for Mu class
GSTs. (b, c) Visualisation of 5 μg of GSH or S-Hexyl GSH agarose-
purified GST subunits of F. hepatica adult worms using two-
dimensional gel electrophoresis (2-DE) and Western blot analysis prob-
ing for Mu class GSTs
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but with GSH columns purifying the Sigma class to a much
lesser extent expressing a preference to purify Mu class GSTs
as observed for pooled samples (Chemale et al. 2006).
The overall GST-ome profile, via GST activity and 2-DE
arrays, demonstrated a general trend of response to TCBZ-SO
exposure. Following exposure, GST-specific activity increased
with increasing TCBZ-SO concentration. In addition, the only
changes noted in both S-Hexyl GSH and GSH agarose purifi-
cations were recorded abundance changes associated with Mu
class GSTs, specifically FhGST-Mu29 and FhGST-Mu26.
Therefore, from activity data and proteomic profiling, it is like-
ly that, of the two GST classes identified, Mu class GSTs are
likely highly important for xenobiotic detoxification with
Sigma class GSTs acting as secondary xenobiotic sequesters
with a primary role as a house-keeping enzyme and as, more
importantly, an immunomodulatory (LaCourse et al. 2012).
This finding of Mu class GST-TCBZ-SO detoxification
supports the work of Chemale et al. (2010) examining the
TCBZ-SO response of TCBZ-resistant and TCBZ-susceptible
isolates. In this case, both FhGST-Mu29 and FhGST-Mu26
responded to TCBZ-SO exposure, in agreement with the cur-
rent study. We identified changes in response to TCBZ-SO
exposure linked to dimer and monomer formation of FhGST-
Mu29 and differential purification of both using the two puri-
fication methods. S-hexyl GSH purification was more efficient
at purifying FhGST-Mu29 dimers compared to GSH agarose
purification. On exposure to TCBZ-SO, a reduction in FhGST-
Mu29 dimers was observed with a corresponding increase in
FhGST-Mu29 monomers purified through GSH agarose. The
novel dimer-monomer GST conformational switch might re-
flect a new liver fluke mechanism in response to TCBZ-SO
challenge. GSTs normally function as dimers but active mono-
meric GSTs have been previously identified in F. hepatica
(Brophy et al. 1990).
Fig. 3 Bioinformatics, expression and purification of recombinant
rFhGST-Mu5. a Multiple sequence alignment of the 4 established
F. hepatica Mu class GSTs and the newly identified FhGST-Mu5. No
other Mu class GSTs were identified within the genome of F. hepatica. A
putative SNAIL/TRAIL motif and their synonymous sequences in para-
sites are in the solid-line grey box. FhGST-Mu5 demonstrates 3 out of the
5 residues match with this motif with a fourth a highly conserved switch
of the leucine residue to an isoleucine. The residues forming the μ-loop
are in dotted-line grey box. Arrowed are predicted GSH-binding sites.
Amino acid sequence identity of FhGST-Mu5 with the four previously
knownMu class GSTs is provided at the end of the alignment. Accession
numbers for each Mu class GST used: FhGST-Mu29/1 (P56598),
FhGST-Mu28/7 (P31671), FhGST-Mu27/47 (P31670) and FhGST-
Mu26/51 (P30112). b Transcript expression levels for FhGST-Mu5 were
analysed from Cwiklinski et al. (2018). c SDS-PAGE gel of the expres-
sion and purification of rFhGST-Mu5. L: E. coli total cytosolic protein
lysate, 10 μg. W1 and W2: column washes removing non-binding pro-
teins, 10 μl. FT: flow through proteins collected after passing through a
GSH-agarose column, 10 μg. E: eluted GSH affinity-purified recombi-
nant rFhGST-Mu5 protein, 2 μg. Arrowed is the band representing
rFhGST-Mu5
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In F. hepatica, there are four recognised isoforms ofMu class
GSTs, i.e. FhGST-Mu26, 27, 28 and 29 (alternatively called
FhGST-Mu51, 47, 7 and 1), with a fifth identified only through
bioinformatics previously (Morphew et al. 2012), and now
cloned and expressed in the current work. Alongside the identi-
fication of FhGST-S1, four of the five Mu class GST isoforms
were identified in the samples examined in the current study
under TCBZ-SO stress. In previous proteomic studies, the same
four classes have also been identified. However, the functional
significance of multiple Mu GSTs is as yet unknown. Multiple
Mu class isoforms might relate to their role in the protection of
the parasite from various classes of xenobiotics derived from the
host bile environment (Brophy et al. 2012). Specifically, the
current work supports a role for FhGST-Mu29 in TCBZ-SO
response via conformational changes as identified by evidence
of altered in dimer/monomer ratios. Of interest, based on tran-
scriptome evidence of Cwiklinski et al. (2018), FhGST-Mu29 is
naturally the highest expressed Mu class GST in adult fluke. In
addition, FhGST-Mu26 ranks third in all Mu class GST expres-
sion (FhGST-Mu29 > Mu27 > Mu26 > Mu5 > Mu28).
Therefore, it is likely that these primary expressed GSTs are
important in binding xenobiotics with structures such as such
as TCBZ-SO.
In many cases, peptides belonging to different GSTs were
identified in a single protein spot providing the identification
of multiple GST isoforms. As reported by Chemale et al.
(2006), this may result from spot overlapping in the 2-DE
gels, as proteins may have a similar pI, potential modifications
and co-migration. Of note is the failure to identify the fifth Mu
class GST, FhGST-Mu5, despite overlapping GST isoforms
identified in multiple spots. Given the sequence similarity of
54% for FhGST-Mu5 compared to FhGST-7, the failure to
identify FhGST-Mu5 is unlikely to be from mis-assigning
sequenced peptides to alternative Mu class GSTs and likely
represents low expression as evidenced from transcriptomics
(Cwiklinski et al. 2018) or, given the poor affinity purification
of FhGST-Mu5, non-binding to affinity columns.
In an attempt to assess if FhGST-Mu5 was not identified in
affinity-purified samples as a result of non-binding, F. hepatica
cytosolicmaterial was probedwith anti-S.mansoniMupolyclon-
al antibodies and compared with the profiles obtained post affin-
ity purification. Given that the same repertoire of protein spots
following Western blotting was visualised on both cytosolic and
affinity-purified fractions, in addition to FhGST-Mu5 recognition
by anti-S. mansoni Mu (data not shown), it seems unlikely that
FhGST-Mu5 was missed in the affinity proteomics study. In
addition, it seems unlikely that FhGST-Mu5 was missed due to
low expression in adults given the identification of FhGST-
Mu28 in the current work and in previous studies (Chemale
et al. 2006). Thus, the potential exists that FhGST-Mu5 is a
low-affinity isoform. In support, Brophy et al. (1990) proposed
that an endogenous ligand interacts with GSTs preventing GST
binding to the affinity matrix generating a ‘low-affinity’ fraction.
Therefore, general inhibitory binding factors are likely present in
the liver fluke cytosol and may be important in flatworm GST
function.
Following the successful induction and expression of
FhGST-Mu5, it is clear that ‘low-affinity’ GSTs are produced
within the GST-ome of F. hepatica yet not all GSTs fail to
bind from potential inhibitory factors. GSH affinity purifica-
tion of rFhGST-Mu5 resulted in low impure yields of recom-
binant protein and suggests that FhGST-Mu5 is a ‘low-affin-
ity’ isoform. Previous studies have all successfully used GSH
affinity chromatography for successful purification of native
Fig. 4 Phylogenetic analysis of the soluble cytosolic GST superfamily.
All reported accession numbers are from GenBank. Where sequences
were identified in silico, only contig numbers are reported. Those from
F. gigantica were taken from the study of Choi et al. (2020), Young et al.
(2011) and transcripts produced by Aberystwyth University. Those from
F. hepatica were taken from the study of Young et al. (2010) and tran-
scripts produced by the University of Liverpool (EBI-ENA archive
ERP000012: an initial characterisation of the F. hepatica transcriptome
using 454-FLX sequencing)
988 Parasitol Res (2021) 120:979–991
and recombinant GSTs (Chemale et al. 2006; LaCourse et al.
2012; Morphew et al. 2012) yet failed to purify FhGST-Mu5.
Thus, to determine if rFhGST-Mu5 is an isoform with ‘low
affinity’ for GSH, the specific activity was determined with
the model substrate CDNB (Habig et al. 1974). The specific
activity of rFhGST-Mu5 was significantly lower than that
recorded for the previously known 4 Mu class GSTs from
F. hepatica (Kalita et al. 2017; Salvatore et al. 1995). This
lower affinity may be correlated with the lower sequence ho-
mology and the more distant grouping of FhGST-Mu5 in
phylogenetic modelling aligning closer to schistosome Mu
class GSTs rather than the previous four F. hepaticaMu class.
Brophy et al. (1990) demonstrated that following
chromatofocusing, 95% of ‘low-affinity’ GSTs were relieved
of their inhibition and thus, based on current evidence, it is
likely that FhGST-Mu5 could indeed be classed as a ‘low-
affinity’Mu class GST as part of the remaining 5% of activity.
Low GSH affinity most likely accounts for the previous lack
of detection during affinity studies with the initial identifica-
tion achieved through transcriptomic analysis (Morphew et al.
2012). Given that FhGST-Mu5 clustered with schistosome
Mu class GSTs during phylogenetics, it is possible that
FhGST-Mu5 and schistosomeMu class GSTs perform similar
roles within these fluke species. Given FhGST-Mu5 was not
purified to homogeneity using GSH affinity, as evidenced by
1D SDS PAGE, additional purification steps are required in
order to biochemically confirm the role of FhGST-Mu5.
The current study represents the first 2-DE profiling of TCBZ-
SO exposed F. hepatica GSTs. However, TCBZ-SO stress in
F. gigantica, and the resulting GST activity, has been previously
investigated. Shehab et al. (2009) examined GST activities from
crude homogenates of adult and juvenile F. gigantica exposed to
TCBZ-SO concentrations. This research indicated that a signifi-
cant increase in the level of GST was present, in both adult and
juvenile flukes, after exposure to TCBZ-SO (Shehab et al. 2009).
Such a significant increase in response to TCBZ-SO prior to
affinity purification was not noted in the current research and
may reflect important differences between F. hepatica and
F. gigantica GST expression. Nevertheless, the work of
Shehab and colleagues further supports the role of Mu class
GST in TCBZ-SO detoxification.
The release of the genome assemblies of F. hepatica
(Cwiklinski et al. 2015; McNulty et al. 2017) has allowed for
further in-depth and complete investigation of the GST-ome
complement of this parasitic flatworm. This has additionally been
supported with the release of a genome for F. gigantica (Choi
et al. 2020). Two new soluble superfamily GSTs were identified
in F. hepatica; a second Sigma (σ) class and a second Omega
(ω) class, on original genes BN1106_s1104B000225 and
BN1106_s50B000678 (scaffolds 1104 and 50, respectively).
BothGSTs contained Pfam IDs for the respective GSTs and both
sequences were successfully amplified through PCR and se-
quence verified. The predicted molecular weight of the sub-
units of the newly identified Sigma andOmegaGSTswas shown
to be 26 and 27 kDa, respectively, and this is in general agree-
ment with known soluble GSTs that have a subunit mass of
between 23 and 28 kDa with an average length of 220 amino
acids (Torres-Rivera and Landa 2008). Gene structure analysing
introns and exons for both the newly identified Sigma and
Omega genes in comparison with the previously identified
F. hepatica Sigma and Omega supported the confirmation of
GST class assignment.
Previous research has demonstrated that model organisms
(humans and mice) both encode for 2 Omega class GST genes
which are widely expressed (Board 2011) reflecting expres-
sion within F. hepatica and now F. gigantica, albeit human
and mice omega GSTs comprise of six exons (Board 2011)
rather than 5 in F. hepatica omega class GSTs. Interestingly,
omega class GSTs have been linked with drug resistance in
human cancers (Townsend and Tew 2003) and Alzheimer’s
disease (Allen et al. 2012) and thus may have some role in
anthelmintic resistance or detoxification not yet discovered.
Sigma class GSTs in F. hepaticawere also initially identified
by Chemale et al. (2006). A recombinant form of F. hepatica
Sigma class GST, FhGST-S1, has since been produced and dem-
onstrated to havemulti-functional roles, including general endog-
enous detoxification, and is strongly linked with prostaglandin
synthesis and the modulation of dendritic cell activity (LaCourse
et al. 2012). Across trematode species, the exon-intron structure
of Sigma class GSTs is conserved. Recently, reports of 5 newly
identified Sigma class GSTs from Clonorchis sinensis consist of
4 exons akin to the two F. hepatica genes (Bae et al. 2016). It
was also noted that the final exon, exon 4, of Sigma GST genes
in the gene predictions of all the trematode species investigated
by Bae et al. (2016) consisted of 225 bp; this conservation of
gene structure likely reflects conserved biological function. As
yet, proteomic investigations have not identified FhGST-S2 from
adult flukes despite their presence in adult transcriptomes. It is
therefore likely that FhGST-S2 remains part of the unbound
fraction of the GST-ome; a likely ‘low-affinity’ sigma class
GST. Interestingly, bioinformatics has revealed a potential ex-
pansion of the Sigma class GSTs within F. giganticawith a third
potential member identified clustering alongside a C. sinensis
Sigma class GST. Further in-depth experimentation will be re-
quired to confirm this finding.
With a key role for GSTs in the detoxification of TCBZ
demonstrated through proteomic profiling, it is now crucial to
understand any involvement ofGSTs in TCBZ resistance. This is
of particular importance given that Scarcella et al. (2012) identi-
fied that fluke resistant to TCBZ expressed significantly higher
levels of GST activity compared to susceptible flukes. The au-
thors suggest that under TCBZ-SO exposure, there is an in-
creased requirement for phase I detoxification of TCBZ-SO, to
the less-effective TCBZ-SO2, and thus also require increased
phase II detoxification, principally from GSTs, to catalyse
TCBZ intermediates. Given the recent bioinformatics
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identification of a potential Cytochrome P450 (Cwiklinski et al.
2015), TCBZ-SO exposure is likely to stimulate this phase I
pathway leading to an increased requirement for phase II
GSTs. Therefore, profiling the specific GST isoforms will give
more insight into resistance mechanisms.
Conclusions
GSTs are a multi-gene family of ubiquitous multifunctional pro-
teins that are predicted to have major roles in detoxifying both
endogenous and exogenous toxins as part of the phase II system.
We have expanded the knowledge on this important protein
family in the parasitic flatwormF. hepatica. In doing so, we have
revealed 5 Mu class, 2 Sigma class (3 in F. gigantica), 2 Omega
class and 1 Zeta class GSTs including novel ‘low-affinity’ Mu
and Sigma class enzymes. In addition, it is clear that GSTs re-
spond to TCBZ-SO exposure and the role of GSTs in TCBZ
resistance awaits further investigation. Finally, the ability to in-
corporate individual fluke for proteomic and sub-proteomic stud-
ies has implications for potential early TCBZ resistance monitor-
ing in liver fluke populations.
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